Skip to main content
logo
Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.5620
-0.0180 (-3.10%)
Jun 3, 2026, 2:29 PM EDT - Market open

Vistagen Therapeutics Revenue

Vistagen Therapeutics had revenue of $303.00K in the quarter ending December 31, 2025, with 29.49% growth. This brings the company's revenue in the last twelve months to $611.50K, up 31.79% year-over-year. In the fiscal year ending March 31, 2025, Vistagen Therapeutics had annual revenue of $486.00K, down -54.32%.

Revenue (ttm)
$611.50K
Revenue Growth
+31.79%
P/S Ratio
29.13
Revenue / Employee
$13,373
Employees
59
Market Cap
22.27M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025486.00K-578.00K-54.32%
Mar 31, 20241.06M1.29M-
Mar 31, 2023-227.00K-1.34M-
Mar 31, 20221.11M19.40K1.78%
Mar 31, 20211.09M--
Mar 31, 2020---
Mar 31, 2019---
Mar 31, 2018---
Mar 31, 20171.25M--
Mar 31, 2016---
Mar 31, 2015---
Mar 31, 2014---
Mar 31, 2013200.40K-1.14M-85.07%
Mar 31, 20121.34M-728.80K-35.19%
Mar 31, 20112.07M--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Palatin Technologies12.88M
Dyadic International3.81M
Marker Therapeutics3.55M
Pluri1.08M
Allarity Therapeutics345.00K
Serina Therapeutics130.00K
Revenue Rankings

VTGN News

More News